Abstract
Micro-organisms express a wide range of transmembrane pumps known as multidrug efflux pumps that improve the micro-organism’s ability to survive in severe environments and contribute to resistance against antibiotic and antimicrobial agents. There is significant interest in developing efflux inhibitors as an adjunct to treatment with current and next generation of antibiotics. A greater understanding of drug recognition and transport by multidrug efflux pumps is needed to develop clinically useful inhibitors, given the breadth of molecules that can be effluxed by these systems. We summarize some structural and functional data that could provide insights into the inhibition of transport mechanisms of these intricate molecular nanomachines with a focus on the advances in computational approaches.
Original language | English |
---|---|
Pages (from-to) | 195-210 |
Number of pages | 16 |
Journal | Future Medicinal Chemistry |
Volume | 8 |
Issue number | 2 |
Early online date | 29 Jan 2016 |
DOIs | |
Publication status | E-pub ahead of print - 29 Jan 2016 |